Suppr超能文献

星状神经节阻滞对咽喉反流病的影响。

Effect of stellate ganglion block on laryngopharyngeal reflux disease.

机构信息

Department of Anesthesiology and Pain Medicine, Soonchunhyang University Hospital, College of Medicine, Soonchunhyang University, Cheonan, Korea.

出版信息

Korean J Anesthesiol. 2013 May;64(5):439-42. doi: 10.4097/kjae.2013.64.5.439. Epub 2013 May 24.

Abstract

BACKGROUND

Laryngopharyngeal reflux (LPR) disease has many symptoms such as globus pharyngeus, excessive throat clearing and hoarseness. The aim of this study was to investigate the effect of stellate ganglion block (SGB) in addition to proton pump inhibitors (PPI) on LPR.

METHODS

Fifty patients complaining of more than 3 typical LPR symptoms for over 3 months were enrolled in the study. The P group took PPI for 8 weeks. The SP group took PPI and interwent a series of 8 SGB procedure once a week during the period of treatment. The blocks were performed one at a time unilaterally on the right and left stellate ganglions by injecting 1% mepivacaine 6 ml. We evaluated the reflux symptom index (RSI) before treatment and following 4 weeks and 8 weeks of treatment in both groups.

RESULTS

After 4 weeks of treatment, the RSI of the P group decreased, but not significantly, to 16.6 ± 6.8 compared with the baseline value of 19.2 ± 2.7 (P = 0.093), whereas the RSI of the SP group decreased significantly to 9.8 ± 3.3 compared with the baseline value of 19.0 ± 4.7 (P = 0.000). After 8 weeks of treatment, the RSI of the P group decreased significantly to 13.7 ± 6.7 (P = 0.001) and the RSI of the SP group also decreased significantly to 7.7 ± 3.4 (P = 0.000). There were significant differences in the RSI between the two groups after 4 weeks (P = 0.000) and 8 weeks (P = 0.001) of treatment.

CONCLUSIONS

The symptoms of LPR improved earlier when PPI therapy was combined with SGB compared with PPI therapy alone.

摘要

背景

咽反流(LPR)疾病有许多症状,如咽部异物感、频繁清嗓和声音嘶哑。本研究旨在探讨星状神经节阻滞(SGB)联合质子泵抑制剂(PPI)治疗 LPR 的效果。

方法

本研究共纳入 50 例 LPR 症状持续 3 个月以上的患者。P 组接受 PPI 治疗 8 周,SP 组在治疗期间每周接受一次 SGB 治疗,共 8 次,每次在右侧和左侧星状神经节各注射 1%甲哌卡因 6ml。我们在治疗前和治疗后 4 周和 8 周评估两组的反流症状指数(RSI)。

结果

治疗 4 周后,P 组的 RSI 虽有所下降,但与治疗前的 19.2 ± 2.7 相比差异无统计学意义(P = 0.093),为 16.6 ± 6.8;而 SP 组的 RSI 明显下降至 9.8 ± 3.3,与治疗前的 19.0 ± 4.7 相比差异有统计学意义(P = 0.000)。治疗 8 周后,P 组的 RSI 明显下降至 13.7 ± 6.7(P = 0.001),SP 组的 RSI 也明显下降至 7.7 ± 3.4(P = 0.000)。治疗 4 周和 8 周后,两组的 RSI 差异均有统计学意义(P 值分别为 0.000 和 0.001)。

结论

与单独使用 PPI 相比,PPI 联合 SGB 治疗可更早改善 LPR 症状。

相似文献

1
Effect of stellate ganglion block on laryngopharyngeal reflux disease.
Korean J Anesthesiol. 2013 May;64(5):439-42. doi: 10.4097/kjae.2013.64.5.439. Epub 2013 May 24.
2
Nissen fundoplication proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale.
World J Gastroenterol. 2017 May 21;23(19):3546-3555. doi: 10.3748/wjg.v23.i19.3546.
3
The Role of Empirical Treatment with Proton Pump Inhibitor as a Diagnostic Tool in Laryngopharyngeal Reflux.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):1744-1751. doi: 10.1007/s12070-019-01750-7. Epub 2019 Oct 21.
7
Transcutaneous electrical acupoint stimulation for suspected laryngopharyngeal reflux disease.
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1815-1825. doi: 10.1007/s00405-022-07698-9. Epub 2022 Oct 14.
9
Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux.
Clin Exp Otorhinolaryngol. 2012 Mar;5(1):28-33. doi: 10.3342/ceo.2012.5.1.28. Epub 2012 Mar 22.
10
Laryngopharyngeal Reflux and GERD: Correlation Between Reflux Symptom Index and Reflux Finding Score.
Indian J Otolaryngol Head Neck Surg. 2019 Oct;71(Suppl 1):684-688. doi: 10.1007/s12070-018-1480-7. Epub 2018 Aug 23.

引用本文的文献

1
Treatment of laryngopharyngeal reflux disease: A systematic review.
World J Clin Cases. 2019 Oct 6;7(19):2995-3011. doi: 10.12998/wjcc.v7.i19.2995.
2
Treatment of persistent postoperative hiccups with stellate ganglion block: Three case reports.
Medicine (Baltimore). 2018 Nov;97(48):e13370. doi: 10.1097/MD.0000000000013370.

本文引用的文献

1
Evaluation and management of laryngopharyngeal reflux.
JAMA. 2005 Sep 28;294(12):1534-40. doi: 10.1001/jama.294.12.1534.
2
Empiric esomeprazole in the treatment of laryngopharyngeal reflux.
Laryngoscope. 2003 Apr;113(4):598-601. doi: 10.1097/00005537-200304000-00003.
3
Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis.
Laryngoscope. 2002 Dec;112(12):2192-5. doi: 10.1097/00005537-200212000-00013.
4
Symptoms and findings of laryngopharyngeal reflux.
Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):10-3.
5
Validity and reliability of the reflux symptom index (RSI).
J Voice. 2002 Jun;16(2):274-7. doi: 10.1016/s0892-1997(02)00097-8.
6
The validity and reliability of the reflux finding score (RFS).
Laryngoscope. 2001 Aug;111(8):1313-7. doi: 10.1097/00005537-200108000-00001.
8
Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole.
South Med J. 1997 Nov;90(11):1115-22. doi: 10.1097/00007611-199711000-00012.
9
Pilot study of the oral omeprazole test for reflux laryngitis.
Otolaryngol Head Neck Surg. 1997 Jan;116(1):41-6. doi: 10.1016/s0194-5998(97)70350-4.
10
Tolerance to oral H2-receptor antagonists.
Dig Dis Sci. 1990 Aug;35(8):976-83. doi: 10.1007/BF01537246.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验